Get Premium to unlock powerful stock data

HealthCor Management, L.P. Buys Bristol-Myers Squibb Co, AmerisourceBergen Corp, Centene Corp, Sells Regeneron Pharmaceuticals Inc, Humana Inc, Danaher Corp

Author's Avatar
insider
Nov 16, 2021
Article's Main Image
New York, NY, based Investment company HealthCor Management, L.P. (Current Portfolio) buys Bristol-Myers Squibb Co, AmerisourceBergen Corp, Centene Corp, Jazz Pharmaceuticals PLC, McKesson Corp, sells Regeneron Pharmaceuticals Inc, Humana Inc, Danaher Corp, Thermo Fisher Scientific Inc, CVS Health Corp during the 3-months ended 2021Q3, according to the most recent filings of the investment company, HealthCor Management, L.P.. As of 2021Q3, HealthCor Management, L.P. owns 73 stocks with a total value of $2.3 billion. These are the details of the buys and sells.

For the details of HealthCor Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/healthcor+management%2C+l.p./current-portfolio/portfolio

These are the top 5 holdings of HealthCor Management, L.P.
  1. Bristol-Myers Squibb Co (BMY) - 3,584,160 shares, 9.15% of the total portfolio. Shares added by 143.10%
  2. Horizon Therapeutics PLC (HZNP) - 1,278,228 shares, 6.04% of the total portfolio. Shares added by 3.50%
  3. Biogen Inc (BIIB) - 466,830 shares, 5.70% of the total portfolio. Shares added by 37.59%
  4. AmerisourceBergen Corp (ABC) - 896,680 shares, 4.62% of the total portfolio. Shares added by 239.21%
  5. Petco Health and Wellness Co Inc (WOOF) - 4,944,450 shares, 4.50% of the total portfolio.
New Purchase: Centene Corp (CNC)

HealthCor Management, L.P. initiated holding in Centene Corp. The purchase prices were between $59.73 and $74.7, with an estimated average price of $66.89. The stock is now traded at around $74.980000. The impact to a portfolio due to this purchase was 2.64%. The holding were 982,630 shares as of 2021-09-30.

New Purchase: Jazz Pharmaceuticals PLC (JAZZ)

HealthCor Management, L.P. initiated holding in Jazz Pharmaceuticals PLC. The purchase prices were between $128.64 and $184.79, with an estimated average price of $151.34. The stock is now traded at around $137.960000. The impact to a portfolio due to this purchase was 2.59%. The holding were 460,790 shares as of 2021-09-30.

New Purchase: Cigna Corp (CI)

HealthCor Management, L.P. initiated holding in Cigna Corp. The purchase prices were between $200.16 and $238.3, with an estimated average price of $217.75. The stock is now traded at around $217.760000. The impact to a portfolio due to this purchase was 1.83%. The holding were 211,780 shares as of 2021-09-30.

New Purchase: Cano Health Inc (CANO)

HealthCor Management, L.P. initiated holding in Cano Health Inc. The purchase prices were between $9.66 and $15.44, with an estimated average price of $12.14. The stock is now traded at around $11.010000. The impact to a portfolio due to this purchase was 1.51%. The holding were 2,754,730 shares as of 2021-09-30.

New Purchase: Becton, Dickinson and Co (BDX)

HealthCor Management, L.P. initiated holding in Becton, Dickinson and Co. The purchase prices were between $238.54 and $262.88, with an estimated average price of $251.45. The stock is now traded at around $244.110000. The impact to a portfolio due to this purchase was 1.49%. The holding were 140,540 shares as of 2021-09-30.

New Purchase: Fate Therapeutics Inc (FATE)

HealthCor Management, L.P. initiated holding in Fate Therapeutics Inc. The purchase prices were between $59.27 and $95.73, with an estimated average price of $78.58. The stock is now traded at around $55.490000. The impact to a portfolio due to this purchase was 0.33%. The holding were 128,450 shares as of 2021-09-30.

Added: Bristol-Myers Squibb Co (BMY)

HealthCor Management, L.P. added to a holding in Bristol-Myers Squibb Co by 143.10%. The purchase prices were between $59.17 and $69.31, with an estimated average price of $65.87. The stock is now traded at around $59.100000. The impact to a portfolio due to this purchase was 5.39%. The holding were 3,584,160 shares as of 2021-09-30.

Added: AmerisourceBergen Corp (ABC)

HealthCor Management, L.P. added to a holding in AmerisourceBergen Corp by 239.21%. The purchase prices were between $112.6 and $125.8, with an estimated average price of $120.16. The stock is now traded at around $123.860000. The impact to a portfolio due to this purchase was 3.26%. The holding were 896,680 shares as of 2021-09-30.

Added: McKesson Corp (MCK)

HealthCor Management, L.P. added to a holding in McKesson Corp by 175.24%. The purchase prices were between $188.42 and $208.66, with an estimated average price of $199.89. The stock is now traded at around $220.610000. The impact to a portfolio due to this purchase was 2.43%. The holding were 442,470 shares as of 2021-09-30.

Added: Tenet Healthcare Corp (THC)

HealthCor Management, L.P. added to a holding in Tenet Healthcare Corp by 188.22%. The purchase prices were between $64.66 and $75.98, with an estimated average price of $70.97. The stock is now traded at around $79.700000. The impact to a portfolio due to this purchase was 2.03%. The holding were 1,084,240 shares as of 2021-09-30.

Added: Envista Holdings Corp (NVST)

HealthCor Management, L.P. added to a holding in Envista Holdings Corp by 92.99%. The purchase prices were between $39.75 and $44.09, with an estimated average price of $42.21. The stock is now traded at around $42.700000. The impact to a portfolio due to this purchase was 1.96%. The holding were 2,249,972 shares as of 2021-09-30.

Added: LivaNova PLC (LIVN)

HealthCor Management, L.P. added to a holding in LivaNova PLC by 421.72%. The purchase prices were between $76.02 and $88.62, with an estimated average price of $82.24. The stock is now traded at around $86.010000. The impact to a portfolio due to this purchase was 1.8%. The holding were 652,150 shares as of 2021-09-30.

Sold Out: Regeneron Pharmaceuticals Inc (REGN)

HealthCor Management, L.P. sold out a holding in Regeneron Pharmaceuticals Inc. The sale prices were between $574.03 and $680.96, with an estimated average price of $621.14.

Sold Out: Humana Inc (HUM)

HealthCor Management, L.P. sold out a holding in Humana Inc. The sale prices were between $389.15 and $471.22, with an estimated average price of $424.73.

Sold Out: Danaher Corp (DHR)

HealthCor Management, L.P. sold out a holding in Danaher Corp. The sale prices were between $272.21 and $332.43, with an estimated average price of $306.96.

Sold Out: Thermo Fisher Scientific Inc (TMO)

HealthCor Management, L.P. sold out a holding in Thermo Fisher Scientific Inc. The sale prices were between $509.53 and $609.78, with an estimated average price of $548.6.

Sold Out: Veeva Systems Inc (VEEV)

HealthCor Management, L.P. sold out a holding in Veeva Systems Inc. The sale prices were between $282.94 and $341, with an estimated average price of $317.34.

Sold Out: Amgen Inc (AMGN)

HealthCor Management, L.P. sold out a holding in Amgen Inc. The sale prices were between $212.27 and $248.7, with an estimated average price of $230.39.



Here is the complete portfolio of HealthCor Management, L.P.. Also check out:

1. HealthCor Management, L.P.'s Undervalued Stocks
2. HealthCor Management, L.P.'s Top Growth Companies, and
3. HealthCor Management, L.P.'s High Yield stocks
4. Stocks that HealthCor Management, L.P. keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus